16 Confirmed Participants
Aesica, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Guerbet, Janssen, Merck Serono, Novartis, NovoNordisk, Orion, Pfizer, Roche, Sanofi, SGS, Takeda and Vetter.

 

Mode of Interaction
We recently launched an exchange platform specifically focused on QC lab excellence. The platform will allow the participants to share and learn from successful practices of pharmaceutical companies. The platform will combine presentations, workshops and in-depth discussions between global QC lab specialist and network excellence leaders with other specialists from pharmaceutical companies. In total, three 2-days meetings are planned.

 

Objective
We want to enable the industry to discuss the exchange topics that are most relevant for the participants. The participants are able to define the topics themselves. Our goal is to allow better problem solving in each of the participants' organizations.

 

Timeline
The first meeting of the exchange platform will take place at the end of September 2018.

If you are interested to learn more about the exchange platform please contact Stephan Köhler.